Drug Profile
Research programme: selective estrogen receptor modulators - CDRI
Alternative Names: CDRI 99373Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Central Drug Research Institute
- Class
- Mechanism of Action Selective estrogen receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Osteoporosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Osteoporosis in India (PO)
- 15 Aug 2007 Preclinical trials in Osteoporosis in India (PO)